Clinical usefulness of T-SPOT.TB test for the diagnosis of tuberculosis

Korean Journal of Laboratory Medicine

Volumn 30, Issue 2, 2010, Pages 171-177

  Kim, Hyun Soo ^a   Kim, Cheol Hong ^a   Hur, Mina ^b   Hyun, In Gyu ^a   Park, Min Jeong ^a   Song, Wonkeun ^a   Park, Ji Young ^a   Kang, Hee Jung ^a   Lee, Kyu Man ^a  

^a Hallym University College of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

ELISPOT; Interferon gamma; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GAMMA INTERFERON;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULOSIS;

ADULT; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 77954841400     PISSN: 15986535     EISSN: None     Source Type: Journal    
DOI: 10.3343/kjlm.2010.30.2.171     Document Type: Article

References (11)

1. Lee JY and Shim TS. Diagnosis of mycobacterium tuberculosis infection using ex-vivo interferon-gamma assay. Tuberc Respir Dis 2006;60:497-509. (Interferon-gamma 2006;60:497-509.)
2. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006;28:24-30.
3. Domínguez J, De Souza-Galvão M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, et al. T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis 2009;63:43-51.
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
5. World Health Organization. Tuberculosis. http://www.who.int/tb (Updated on 2009).
6. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005;293:2756-61.
7. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, et al. Usefulness of whole-blood interferon-γ assay and interferon-γ enzymelinked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132:959-65.
8. American Thoracic Society. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161:1376-95.
9. Clinical and Laboratory Standards Institute. User protocol for evaluation of qualitative test performance; Approved guideline-Second edition. CLSI document EP12-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
10. Linnet K and Boyd JC. Selection and analytical evaluation of methods-with statistical technique. Burtis CA, Ashwood ER, et al., eds. Tietz textbook of clinical chemistry and molecular diagnostics. 4th ed. St. Louis: Elsevier Saunders, 2006:367-8.
11. Provinciali M, Moresi R, Donnini A, Lisa RM. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly. Gerontology 2009; 55:314-21.